At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Radiesse injectable implant and 2% lidocaine HCLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Radiesse® Post Approval Safety Study - Radiological Evaluation of Implantation in the Hands
In Brief
A clinical study evaluating Radiesse injectable implant and 2% lidocaine HCL for Volume Loss in the Dorsum of the Hand. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The objective of this study is to provide a preliminary assessment of the radiographic appearance of Radiesse material that has been injected into the dorsum of the hands.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVolume Loss in the Dorsum of the Hand
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartDec 2015
First PostedOct 2016
Primary CompletionJan 2018
TodayJul 2026
First PostedOct 31, 2016
Enrollment StartDec 1, 2015
Primary CompletionJan 2, 2018
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 9.7 years ago
Interventions
Radiesse injectable implant and 2% lidocaine HCLdevice
Radiesse injectable implant injected in small boluses (0.2-0.5cc/bolus). No more than 0.5cc per bolus. No more than 3 cc (2 syringes) will be injected per hand.